NPPA fixes prices of 12 formulations including Brufen Plus,Vitamin D3; check out details
New Delhi: National drug pricing regulator NPPA said it has fixed the retail/ceiling prices of 12 formulations including those used for the treatment of diabetes, various types of cancer, heart attack, fever, multiple myeloma, epilepsy, and seizures.
NPPA has fixed the retail prices of 9 formulations and ceiling prices of 3 schedule formulations.
Through its recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has fixed/revised the retail/ceiling prices of 12 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).
Following are the details
Sl.No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Atorvastatin + Aspirin Capsule (Atchol-ASP 150) | Each hard gelatin capsule contains: Atorvastatin Calcium eq. to Atorvastatin 10mg (as two film -coated tablets of 5 mg each) Aspirin 150mg (as two enteric coated tablets of 75mg each) | 1 Capsule | M/s Aristo Pharmaceuticals Pvt. Ltd. | 2.10 |
2. | Nifedipine + Lidocaine Cream (LOXHEAL) | Each 30mg cream contains: Nifedipine IP 0.3 percent w/w, Lidocaine IP 1.5 percent w/w, Imidurea IP (as Preservative) 0.2percent w/w in Cream base | 1 GM | M/s Uttaranchal Biotech Ltd. / M/s Neon Laboratories Ltd. | 3.14 |
3. | Pioglitazone + Gliclazide + Metformin Tablet (GLZ Total) | Each film coated tablet contains: Pioglitazone HCL IP eq. to Pioglitazone 15mg, Gliclazide IP 60mg (In modified release form) and Metformin HCL 500mg (extended release form) | 1 Tablet | M/s M/s Mascot Health Seris Pvt. Ltd. / M/s Alembic Pharmaceuticals Limited | 8.11 |
4. | Ibuprofen + Paracetamol Tablet (Brufen Plus) | Each film coated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg | 1 Tablet | M/s Innova Captab Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd | 1.04 |
5. | Misoprostol Tablet | Each uncoated tablet contains: Misoprostol IP 600mcg (As 1% Misoprostol dispersion) | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s Bharat Serums and Vaccines Limited | 56.81 |
6. | Glimepiride + Metformin Tablet | Each uncoated bilayered tablet contains: Glimepiride IP 3mg, Metformin Hydrochloride IP 850mg (in Sustained release form) | 1 Tablet | M/s Windlas Biotech Ltd. / M/s Intas Pharmaceuticals Limited | 7.05 |
7. | Melphalan + Povidone Injection (Melphalan Injection IP 50mg) | Each vial contains: Melphalan HCL IP eq. to Melphalan 50mg, Povidone IP 20mg and Diluent For Melphalan Injection 10ml each vial contains Sodium Citrate IP 0.2g Proylene Glycol IP 6ml Ethanol (96%) IP 0.52ml water for Injection | Each Pack | M/s Natco Pharma Ltd | 1767.38 |
8. | Trastuzumab Injection | Each Lyophilized vial contains: Trastuzumab 150mg Injection | 1 Vial | M/s Cadila Healthcare Limited / M/s Emcure Pharmaceuticals Ltd. | 18125.79 |
9. | Vitamin D3 (Cholecalciferol) (DRISE SURE) | Each orally Disintegrating Strip contains: Vitamin D3 (Cholecalciferol) IP 60000 IU Orally Disintegrating Strip | 1 Orally Disintegrating Strip | M/s Zim Laboratories Limited / M/s USV Limited | 24.76 |
Sl. No. | Name of the Scheduled Formulation | Dosage form & Strength | Unit | Ceiling Price (Rs.) | Review Order number and date | Existing SO number and date |
(1) | (2) | (3) | (4) | (5) | (6) | (7) |
1. | Furosemide | Injection 10mg/ml | 1 ML | 1.50 | 31015/19/2017- Pricing dated 24.08.2017 | 2058(E) dated 30.6.2017 (at Sl. No. 244) |
2. | Snake Venom Antiserum-Soluble/ Liquid Polyvalent | Injection | Each Pack (10 ML) | 392.64 | 31015/56/2017- Pricing dated 30.10.2017 | 2058(E) dated 30.6.2017 (at Sl. No. 539) |
3. | Phenobarbitone | Oral liquid 20 mg/5 ml | 1 ML | 0.40 | 31015/37/2017- Pricing dated 28-09-2017 | 2058(E) dated 30.6.2017 (at Sl. No. 469) |
Below are the attachments for the same.
http://www.nppaindia.nic.in/ceiling/press05March18/Formulation_Prices(09).pdf
http://www.nppaindia.nic.in/ceiling/press05March18/Formulation_Prices(03).pdf
Medical Dialogues had earlier reported that NPPA had fixed the retail prices of 14 formulations under the Drugs (Prices Control) Order, 2013 exclusive of goods and services tax (GST).
Read also: NPPA fixes retail prices of 14 formulations, check out details
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd